Pliant raises $80M to open its B2B payments platform to AI agents
Berlin fintech Pliant has raised an $80M Series C to open its B2B payments infrastructure to AI agents, the company said on Wednesday. Seaya Nova
another news portal
Berlin fintech Pliant has raised an $80M Series C to open its B2B payments infrastructure to AI agents, the company said on Wednesday. Seaya Nova
Mario Stifano is chief executive of Galantas Gold, a gold and copper company listed on the TSX Venture Exchange in Toronto and on AIM in
Microsoft has filed a patent application for a new AI technology that can alter what people say during live broadcasts. The technology is designed to
Ranked-choice voting may decide Alaska’s Senate outcome, while Mississippi’s race hangs on a knife’s edge.
A group of former Israeli military generals offered their help to Palestinian olive farmers in the occupied West Bank.
Votes are being counted across South Africa after a record 29.2 million people registered to vote.
It’s the end of an era: NASA’s Swift telescope has reached the conclusion of its nearly 22-year mission, burning up in Earth’s atmosphere after studying
Archaeologists in Ukraine have found a colorful belt buckle that may have been worn by a nomadic equestrian warrior 1,800 years ago on the fringes
A noxious gas found seeping through cracks on Mars hints that there may be magma flowing beneath the Red Planet’s surface — and perhaps even
Google is switching off Gemini, Gemini Notebook, Gemini in Classroom, and Search for K-12 student accounts by default. They stay off until a school admin
Sam Altman, the OpenAI CEO, said it’s “quite terrible” that so much of the world’s limited DRAM sits in personal computers that use it maybe
Thousands of people suffer with tailbone pain, often struggling to find an accurate diagnosis and effective treatment.
Women with the inherited cholesterol condition familial hypercholesterolemia may be at a slightly higher risk of developing pre-eclampsia, a pregnancy condition that can cause serious
Dialysis should not necessarily be regarded as the default option for older people with kidney failure, the first randomized study of its kind in the